Home Visit
Upload
- TruHealth Basic ₹1000
- TruHealth Essential ₹1700
- TruHealth Vital ₹2300
- Truhealth Vital with Body Vitals Check & Consult ₹2700
- TruHealth Vital Plus ₹3000
- Truhealth Vital Plus with Body Vitals Check & Consult ₹3400
- TruHealth Active Female ₹4000
- TruHealth Active Male ₹4000
- Truhealth Active (Male) with Body Vitals Check & Consult ₹4400
- Truhealth Active (Female) with Body Vitals Check & Consult ₹4400
- TruHealth ProActive Male ₹5000
- TruHealth ProActive Female ₹5000
- Truhealth Proactive (Male) with Body Vitals Check & Consult ₹5400
- Truhealth Proactive (Female) with Body Vitals Check & Consult ₹5400
- TruHealth Expert Male ₹6000
- TruHealth Expert Female ₹6000
- Truhealth Expert (Male) with Body Vitals Check & Consult ₹6400
- Truhealth Expert (Female) with Body Vitals Check & Consult ₹6400
- TruHealth Diabetes Monitor ₹1800
- TruHealth BP Monitor ₹3740
- TruHealth Weight Monitor ₹4180
- TruHealth PCOS Monitor ₹4270
- TruHealth Alcohol Impact Monitor ₹4620
- TruHealth Lipid Monitor ₹4855
- TruHealth Vitamin & Mineral Monitor ₹5280
- TruHealth Fatigue Monitor ₹5880
- TruHealth Hair Loss Monitor ₹8655
.png)
Leukemia Panel-AML Mutation, Blood in Akola
No special precautions
Sample Type
Blood
Recommended for
Male, Female
Report
Within 24 Hours
Blood test at Home
NABL & CAP Accredited Labs
Accurate & Quality Test Reports
Trusted by Leading Doctors & Hospitals
Overview
Mutations in the FLT3, NPM1, and CEBPA genes play a crucial role in the development and progression of acute myelogenous leukaemia (AML). The Leukemia Panel-AML Mutation test, performed on blood samples, is designed to detect mutations in the FLT3, NPM1, and CEBPA genes. The assay focuses on these specific genes as they have clinical utility in risk stratification for patients with newly diagnosed cytogenetically normal acute myelogenous leukemia (CN-AML). CN-AML refers to cases where standard cytogenetic analysis does not reveal any chromosomal abnormalities. By analyzing mutations in FLT3, NPM1, and CEBPA, the Leukemia Panel-AML Mutation test aids in determining the risk profile and prognosis for individuals with CN-AML. Mutations in FLT3, such as internal tandem duplications (ITD), are associated with a poor prognosis, while NPM1 and CEBPA mutations are considered favorable prognostic markers. This information helps healthcare professionals in making informed treatment decisions and selecting appropriate therapeutic strategies for CN-AML patients, ultimately improving patient outcomes.
Leukemia Panel-AML Mutation, Blood Price in Akola
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Leukemia Panel-AML Mutation, Blood with a clear pricing structure
The price of Leukemia Panel-AML Mutation, Blood in Akola is ₹ 9,000
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
WhatsApp
